Skip to content

Altimmune ALT Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-42.7%+7.8pp-50.6%+2.0pp-52.6%+3.3pp-55.9%+1.4pp-57.3%+2.6pp
Return on assets-37%+5.1pp-42%+3.8pp-45.8%+2.4pp-48.3%+4.0pp-52.2%+2.1pp
Liquidity
Current ratio29.6×+11.0×18.5×+1.4×17.2×-3.3×20.4×+4.6×15.8×+2.7×
Quick ratio29.6×+11.0×18.5×+1.4×17.2×-3.3×20.4×+4.6×15.8×+2.7×
Cash ratio8.6×+5.7×2.9×-1.9×4.9×-15.0×19.9×+14.8×+1.5×
Leverage
Debt-to-equity0.1×0.0×0.2×+0.1×0.1×0.0×0.1×+0.1×0.0×
Debt-to-assets0.1×0.0×0.1×+0.1×0.1×0.0×0.1×+0.1×0.0×
Interest coverage-35.9×+21.9×-57.8×+61.1×-118.9×+228×-346.9×+10,563×-10,910.3×+553×
Per Share
Book value per share$2.28-10.6%$2.55+23.0%$2.08+4.8%$1.98+5.2%$1.88+8.2%
Valuation
Market capitalization$558.14M-2.1%$376.68M+13.2%$332.73M-42.9%$583.16M+51.4%$385.07M-24.9%
Enterprise value$495.27M-5.0%$368.56M+28.8%$286.14M-31.0%$414.58M+23.3%$336.17M-29.6%
Price / book-2.0×1.7×-0.1×1.8×-1.8×3.6×+0.9×2.7×-1.4×
Earnings yield-16.3%-0.5pp-23.4%+1.8pp-25.2%-10.2pp-15%+8.4pp-23.4%-4.9pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Altimmune's ratios come from?
Every ratio is computed from Altimmune's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.